Unique ID issued by UMIN | UMIN000044793 |
---|---|
Receipt number | R000051156 |
Scientific Title | Safety and Efficacy of Radiofrequency Catheter Ablation of Atrial Fibrillation Drivers as Identified by Fractionated Atrial Potentials (FrAP) Mapping, Using the Rhythmia 3-D Mapping System in Patients with Recurrent Atrial Fibrillation After Prior Pulmonary Vein Isolation Procedure |
Date of disclosure of the study information | 2021/08/01 |
Last modified on | 2024/01/15 12:30:48 |
Safety and Efficacy of Radiofrequency Catheter Ablation of Atrial Fibrillation Drivers as Identified by Fractionated Atrial Potentials (FrAP) Mapping,
Using the Rhythmia 3-D Mapping System in Patients with Recurrent Atrial Fibrillation
After Prior Pulmonary Vein Isolation Procedure
FrAP- Ablation Study
Safety and Efficacy of Radiofrequency Catheter Ablation of Atrial Fibrillation Drivers as Identified by Fractionated Atrial Potentials (FrAP) Mapping,
Using the Rhythmia 3-D Mapping System in Patients with Recurrent Atrial Fibrillation
After Prior Pulmonary Vein Isolation Procedure
FrAP- Ablation Study
Japan | North America |
atrial fibrillation
Cardiology |
Others
NO
To investigate efficacy and safety of Frap ablation in patients with recurrent atrial fibrillation after PV isolation
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Freedom from atrial fibrillation, atrial flutter or atrial tachycardia during 1-year after catheter ablation procedure.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
In addition to pulmonary vein re-isolation, Frap ablation is performed.
20 | years-old | <= |
85 | years-old | > |
Male and Female
1) patients, having histories of prior catheter ablation (mainly PV isolation), with Symptomatic atrial fibrillation.
2) Documentation of AF between the previous session and the enrollment of the study.
3) Refractory or intolerent to antiarrhythmic drugs.
1)Initial procedure failed to isolate one or more PVs
2)Left atrial size > 6.1 cm (Anterior-Posterior Dimension)
3)LVEF <35 %
4)Severe mitral regurgitation
5)Prior mitral valve surgery with mechanical valve replacement
6)Intracardiac thrombus present on pre-procedure TTE, TEE. or CT
7)Preexisting severe pulmonary vein stenosis (>75% narrowing)
8)Comorbidity with life-expectancy < 2 years
9)Unable to be on anticoagulation for the purpose of stroke prevention
10)Untreated thyroild dysfunction
11)End-stage renal disease (eGFR<15 or requirement of hemodialysis)
150
1st name | Yuichiro |
Middle name | |
Last name | Sakamoto |
Toyohashi Heart Center
Cardiovascular medicine
441-8530
21-1 Gobudori, Oyama-cho, Toyohashi
0532373377
sakamoto@heart-center.or.jp
1st name | Yuichiro |
Middle name | |
Last name | Sakamoto |
Toyohashi Heart Center
Cardiovascular medicine
441-8530
21-1 Gobudori, Oyama-cho, Toyohashi
0532373377
sakamoto@heart-center.or.jp
Toyohashi Heart Center
None
Self funding
Toyohashi Heart Center
21-1 Gobudori, Oyama-cho, Toyohashi
0532373377
heart-chiken@heart-center.or.jp
NO
豊橋ハートセンター(愛知県)、名古屋ハートセンター(愛知県)、小倉記念病院(福岡県)、県立尼崎総合医療センター(兵庫県)、一宮西病院(愛知県)、クリーブランドクリニック(オハイオ州)
2021 | Year | 08 | Month | 01 | Day |
Unpublished
No longer recruiting
2021 | Year | 04 | Month | 28 | Day |
2021 | Year | 04 | Month | 27 | Day |
2021 | Year | 08 | Month | 01 | Day |
2025 | Year | 01 | Month | 31 | Day |
2021 | Year | 07 | Month | 08 | Day |
2024 | Year | 01 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051156